Angioscope Device Market by Usability, End User

List of Tables

[183 Pages Report] The Angioscope Device Market size was estimated at USD 251.58 million in 2023 and expected to reach USD 266.77 million in 2024, at a CAGR 6.50% to reach USD 391.20 million by 2030.

The angioscope device market includes an arena of medical devices designed for angioscopy, a procedure that allows healthcare professionals to visualize the interior of blood vessels and organs through a small, flexible tube equipped with a light source and camera known as an angioscope. An increase in conditions such as peripheral artery disease and coronary artery disease fuels the demand for diagnostic and therapeutic procedures involving angioscopy. Innovations in angioscope devices, including enhanced imaging capabilities and user-friendly interfaces, have improved their functionality and effectiveness, attracting more healthcare providers. Rising preference for minimally invasive surgeries among patients and doctors alike for their benefits over traditional open surgeries supports market expansion. However, stringent regulatory requirements for approval of medical devices can delay market entry for new innovations, limiting the market scope. Ensuring the quality and reliability of intricate angioscope systems demands significant expertise and training, posing challenges for healthcare providers. Moreover, coupling angioscope devices with digital tools such as AI for better imaging analysis and patient monitoring may offer new avenues for growth in the market. Ongoing research into compact, wearable angioscope technology could revolutionize outpatient care and remote monitoring, generating opportunities for market expansion in upcoming years.

KEY MARKET STATISTICS
Base Year [2023]	USD 251.58 million
Estimated Year [2024]	USD 266.77 million
Forecast Year [2030]	USD 391.20 million
CAGR (%)	6.50%

Regional Insights

In the Americas, particularly in the United States and Canada, there is a high demand for advanced medical technologies due to an aging population and a significant prevalence of cardiovascular diseases. High healthcare expenditure and favorable reimbursement policies further support adopting these technologies in the Americas region. European Union countries strongly prefer high-standard medical treatments supported by extensive public healthcare systems and health insurance coverage. Europe's stringent regulatory environment ensures that only the most reliable and effective devices are available in the market, with Germany, France, and the UK leading in medical device usage. The Middle East and Africa region presents a mixed scenario where the Gulf Cooperation Council (GCC) countries such as Saudi Arabia and the UAE show increasing investment in health technology, including angioscope devices. Asia Pacific is a rapidly growing region in the market for angioscope devices, and factors such as increasing healthcare infrastructure, rising medical tourism, and growing health awareness are contributing to the market growth in the region. Japan stands out as a significant market with advanced healthcare technologies and substantial investment in medical research. China and India are emerging markets with increasing adoption rates due to improving healthcare policies and the rise of middle-class populations demanding better medical care.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Angioscope Device Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
- Rising incidence of cardiovascular diseases
- Ongoing technological innovations in angioscope devices
- Growing preference for minimally invasive surgeries

Market Restraints
- Technical challenges and quality concerns related to intricate angioscope systems

Market Opportunities
- Development of advanced imaging techniques
- R&D initiatives in wearable and portable solutions

Market Challenges
- Stringent regulatory requirements for approval of medical devices

Market Segmentation Analysis
- Usability: Increasing preference for reusable angioscopes due to convenience and cost considerations
- End User: Diverse scope of applications in diagnostic centers for efficient patient evaluation

Market Disruption Analysis
Porter's Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Angioscope Device Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Angioscope Device Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Abbott's Introduction of AI-Enhanced Vascular Imaging in India, Revolutionizing Cardiac Care

Abbott Laboratories has introduced a cutting-edge vascular imaging platform in India, which is enhanced by Ultreon 1.0 Software. The advanced system integrates optical coherence tomography (OCT) with artificial intelligence (AI) to provide doctors with a detailed view of blood flow and vessel blockages, enabling precise measurements of vessel diameters. The newly launched technology substantially improves the accuracy of stent deployment during coronary procedures by offering real-time, high-definition imagery from within the blood vessels. [Published On: 2023-10-17]

Canon Medical Launches Alphenix Evolve Edition Angiography System in European Market

Canon Medical Systems Corporation has launched the Alphenix / Evolve Edition angiography system, designed to support percutaneous coronary intervention (PCI) and structural heart disease procedures by utilizing deep learning technology for enhanced imaging and reduced operational times and radiation doses. The system is a part of Canon Medical's aEvolve portfolio, which integrates AI-driven technologies to aid real-time diagnostic and therapeutic decision-making processes seamlessly within existing workflows. [Published On: 2023-08-07]

Abbott Acquires Cardiovascular Systems, Inc. to Enhance Vascular Treatment Technologies

Abbott Laboratories has entered into a definitive agreement to acquire Cardiovascular Systems, Inc. (CSI), a pioneer in the development of atherectomy systems for the treatment of arterial diseases, for approximately USD 890 million. The acquisition is set to enrich Abbott's portfolio with cutting-edge vascular technologies and an experienced team, reinforcing its position in the vascular intervention market. [Published On: 2023-02-08]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Angioscope Device Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Angioscope Device Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Boston Scientific Corporation, Canon Medical Systems, Cardinal Health, Cook Medical, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Medical Corporation, Johnson & Johnson Services, Inc., Karl Storz, LivaNova PLC, Medtronic PLC, Olympus Corporation, Philips Healthcare, Shimadzu Corporation, Siemens Healthineers, Smith & Nephew PLC, Stryker Corporation, Terumo Corporation, Vena Medica, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Angioscope Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

Usability
- Disposable Angioscopes
- Reusable Angioscopes

End User
- Diagnostic Centers
- Hospitals
- Research & Academic Institutes
- Specialty Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

Product Code: MRR-6B0EA07975A0

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising incidence of cardiovascular diseases
  - 5.1.1.2. Ongoing technological innovations in angioscope devices
  - 5.1.1.3. Growing preference for minimally invasive surgeries
- 5.1.2. Restraints
  - 5.1.2.1. Technical challenges and quality concerns related to intricate angioscope systems
- 5.1.3. Opportunities
  - 5.1.3.1. Development of advanced imaging techniques
  - 5.1.3.2. R&D initiatives in wearable and portable solutions
- 5.1.4. Challenges
  - 5.1.4.1. Stringent regulatory requirements for approval of medical devices
5.2. Market Segmentation Analysis
- 5.2.1. Usability: Increasing preference for reusable angioscopes due to convenience and cost considerations
- 5.2.2. End User: Diverse scope of applications in diagnostic centers for efficient patient evaluation
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Angioscope Device Market, by Usability

6.1. Introduction
6.2. Disposable Angioscopes
6.3. Reusable Angioscopes

7. Angioscope Device Market, by End User

7.1. Introduction
7.2. Diagnostic Centers
7.3. Hospitals
7.4. Research & Academic Institutes
7.5. Specialty Clinics

8. Americas Angioscope Device Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Angioscope Device Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Angioscope Device Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
- 11.3.1. Abbott's Introduction of AI-Enhanced Vascular Imaging in India, Revolutionizing Cardiac Care
- 11.3.2. Canon Medical Launches Alphenix Evolve Edition Angiography System in European Market
- 11.3.3. Abbott Acquires Cardiovascular Systems, Inc. to Enhance Vascular Treatment Technologies
11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

12.1. Key Company Profiles
12.2. Key Product Portfolio